Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Apr;71(4):840–849. doi: 10.1172/JCI110838

Structure-Activity Relationships of Somatostatin Analogs in the Rabbit Ileum and the Rat Colon

Linda E Rosenthal 1,2, Darrell J Yamashiro 1,2, Jean Rivier 1,2, Wylie Vale 1,2, Marvin Brown 1,2, Kiertisin Dharmsathaphorn 1,2
PMCID: PMC436941  PMID: 6131906

Abstract

Somatostatin increases absorption of electrolytes and inhibits diarrhea in patients with endocrine tumors and short bowel syndrome. In an attempt to develop a gut-specific somatostatin analog, each amino acid in the somatostatin molecule was replaced with L-alanine, deleted, or substituted with its D-isomer. The potency of each analog to stimulate ion transport in the rabbit ileum was then determined using the modified Ussing chamber technique. The results were compared to the ability of each analog to inhibit the stimulated release of growth hormone from cultured rat anterior pituitary cells and to inhibit the arginine-stimulated release of insulin and glucagon in the rat in vivo. Analogs that showed gut selectivity were then tested for their ion transport properties in the rat colon. Results: (a) Substitution with L-alanine or deletion of the amino acid at position 6, 7, 8, or 9 and deletion of Threonine10-produced analogs with significantly reduced ion transport properties to <4% of somatostatin's action. The substitution also markedly reduced the ability of the compounds to inhibit the release of growth hormone, insulin, and glucagon. (b) Selectivity of intestinal ion transport was achieved by any one of the following alterations: L-alanine substitution at Phenylalanine11, deletion of Phenylalanine11, substitution with D-lysine at Lysine4, or substitution with L-alanine at Lysine4. These compounds had intestinal ion transport properties of 52, 34, 139, and 94%, respectively, while demonstrating little or no inhibition of growth hormone, insulin or glucagon release. Conclusions: (a) Phenylalanine6, Phenylalanine7, Tryptophan8, and Lysine9 are required for the ion transport and other biologic actions of somatostatin, whereas Threonine10 serves as an essential spacer. (b) Alteration at Phenylalanine11 or Lysine4 yields analogs that are selective for ion transport in the rabbit ileum and rat colon. These findings should be taken into consideration when developing a gut-specific somatostatin analog that can be useful in the treatment of diarrhea.

Full text

PDF
840

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benoit R., Böhlen P., Brazeau P., Ling N., Guillemin R. Isolation and characterization of rat pancreatic somatostatin. Endocrinology. 1980 Dec;107(6):2127–2129. doi: 10.1210/endo-107-6-2127. [DOI] [PubMed] [Google Scholar]
  2. Binder H. J., Powell D. W., Tai Y. H., Curran P. F. Electrolyte transport in rabbit ileum. Am J Physiol. 1973 Oct;225(4):776–780. doi: 10.1152/ajplegacy.1973.225.4.776. [DOI] [PubMed] [Google Scholar]
  3. Bloom S. R. Somatostatin and the gut. Gastroenterology. 1978 Jul;75(1):145–147. [PubMed] [Google Scholar]
  4. Bohlen P., Benoit R., Ling N., Guillemin R., Brazeau P. Isolation and characterization of rat hypothalamic somatostatin-14. Endocrinology. 1981 May;108(5):2008–2010. doi: 10.1210/endo-108-5-2008. [DOI] [PubMed] [Google Scholar]
  5. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  6. Brown M., Rivier J., Vale W. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat. Endocrinology. 1976 Feb;98(2):336–343. doi: 10.1210/endo-98-2-336. [DOI] [PubMed] [Google Scholar]
  7. Brown M., Rivier J., Vale W. Somatostatin: analogs with selected biological activities. Science. 1977 Jun 24;196(4297):1467–1469. doi: 10.1126/science.867045. [DOI] [PubMed] [Google Scholar]
  8. Brown M., Rivier J., Vale W. Somatostatin: central nervous system actions on glucoregulation. Endocrinology. 1979 Jun;104(6):1709–1715. doi: 10.1210/endo-104-6-1709. [DOI] [PubMed] [Google Scholar]
  9. Carter R. F., Bitar K. N., Zfass A. M., Makhlouf G. M. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. Gastroenterology. 1978 Apr;74(4):726–730. [PubMed] [Google Scholar]
  10. Davis G. R., Camp R. C., Raskin P., Krejs G. J. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. Gastroenterology. 1980 Feb;78(2):346–349. [PubMed] [Google Scholar]
  11. Dharmsathaphorn K., Binder H. J., Dobbins J. W. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology. 1980 Jun;78(6):1559–1565. [PubMed] [Google Scholar]
  12. Dharmsathaphorn K., Gorelick F. S., Sherwin R. S., Cataland S., Dobbins J. W. Somatostatin decreases diarrhea in patients with the short-bowel syndrome. J Clin Gastroenterol. 1982 Dec;4(6):521–524. doi: 10.1097/00004836-198212000-00008. [DOI] [PubMed] [Google Scholar]
  13. Dharmsathaphorn K., Racusen L., Dobbins J. W. Effect of somatostatin on ion transport in the rat colon. J Clin Invest. 1980 Oct;66(4):813–820. doi: 10.1172/JCI109919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dharmsathaphorn K., Sherwin R. S., Cataland S., Jaffe B., Dobbins J. Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med. 1980 Jan;92(1):68–69. doi: 10.7326/0003-4819-92-1-68. [DOI] [PubMed] [Google Scholar]
  15. Dharmsathaphorn K., Sherwin R. S., Dobbins J. W. Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology. 1980 Jun;78(6):1554–1558. [PubMed] [Google Scholar]
  16. Efendić S., Mattsson O. Effect of somatostatin on intestinal motility. Acta Radiol Diagn (Stockh) 1978;19(2):348–352. doi: 10.1177/028418517801900209. [DOI] [PubMed] [Google Scholar]
  17. Gerich J. E., Patton G. S. Somatostatin. Physiology and clinical applications. Med Clin North Am. 1978 Mar;62(2):375–392. doi: 10.1016/s0025-7125(16)31813-2. [DOI] [PubMed] [Google Scholar]
  18. Guandalini S., Kachur J. F., Smith P. L., Miller R. J., Field M. In vitro effects of somatostatin on ion transport in rabbit intestine. Am J Physiol. 1980 Feb;238(2):G67–G74. doi: 10.1152/ajpgi.1980.238.2.G67. [DOI] [PubMed] [Google Scholar]
  19. Hobart P., Crawford R., Shen L., Pictet R., Rutter W. J. Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish. Nature. 1980 Nov 13;288(5787):137–141. doi: 10.1038/288137a0. [DOI] [PubMed] [Google Scholar]
  20. Johansson C., Efendic S., Wisén O., Uvnäs-Wallensten K., Luft R. Effects of short-time somatostatin infusion on the gastric and intestinal propulsion in humans. Scand J Gastroenterol. 1978;13(4):481–483. doi: 10.3109/00365527809181925. [DOI] [PubMed] [Google Scholar]
  21. Meyers C. A., Coy D. H., Huang W. Y., Schally A. V., Redding T. W. Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography. Biochemistry. 1978 Jun 13;17(12):2326–2331. doi: 10.1021/bi00605a011. [DOI] [PubMed] [Google Scholar]
  22. Meyers C. A., Coy D. H., Murphy W. A., Redding T. W., Arimura A., Schally A. V. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. Proc Natl Acad Sci U S A. 1980 Jan;77(1):577–579. doi: 10.1073/pnas.77.1.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murphy W. A., Meyers C. A., Coy D. H. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs. Endocrinology. 1981 Aug;109(2):491–495. doi: 10.1210/endo-109-2-491. [DOI] [PubMed] [Google Scholar]
  24. Rivier J. E. Somatostatin. Total solid phase synthesis. J Am Chem Soc. 1974 May 1;96(9):2986–2992. doi: 10.1021/ja00816a053. [DOI] [PubMed] [Google Scholar]
  25. Rivier J., Brazeau P., Vale W., Guillemin R. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. J Med Chem. 1975 Feb;18(2):123–126. doi: 10.1021/jm00236a001. [DOI] [PubMed] [Google Scholar]
  26. Rivier J., Brown M., Vale W. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun. 1975 Jul 22;65(2):746–751. doi: 10.1016/s0006-291x(75)80208-7. [DOI] [PubMed] [Google Scholar]
  27. Sarantakis D., McKinley W. A., Jaunakais I., Clark D., Grant N. H. Structure activity studies on somatostatin. Clin Endocrinol (Oxf) 1976;5 (Suppl):275S–278S. doi: 10.1111/j.1365-2265.1976.tb03835.x. [DOI] [PubMed] [Google Scholar]
  28. Schally A. V., Dupont A., Arimura A., Redding T. W., Nishi N., Linthicum G. L., Schlesinger D. H. Isolation and structure of somatostatin from porcine hypothalami. Biochemistry. 1976 Feb 10;15(3):509–514. doi: 10.1021/bi00648a009. [DOI] [PubMed] [Google Scholar]
  29. Vale W., Grant G., Amoss M., Blackwell R., Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology. 1972 Aug;91(2):562–572. doi: 10.1210/endo-91-2-562. [DOI] [PubMed] [Google Scholar]
  30. Vale W., Rivier C., Brown M. Regulatory peptides of the hypothalamus. Annu Rev Physiol. 1977;39:473–527. doi: 10.1146/annurev.ph.39.030177.002353. [DOI] [PubMed] [Google Scholar]
  31. Vale W., Rivier J., Ling N., Brown M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism. 1978 Sep;27(9 Suppl 1):1391–1401. doi: 10.1016/0026-0495(78)90081-1. [DOI] [PubMed] [Google Scholar]
  32. Veber D. F., Freidlinger R. M., Perlow D. S., Paleveda W. J., Jr, Holly F. W., Strachan R. G., Nutt R. F., Arison B. H., Homnick C., Randall W. C. A potent cyclic hexapeptide analogue of somatostatin. Nature. 1981 Jul 2;292(5818):55–58. doi: 10.1038/292055a0. [DOI] [PubMed] [Google Scholar]
  33. Veber D. F., Holly F. W., Paleveda W. J., Nutt R. F., Bergstrand S. J., Torchiana M., Glitzer M. S., Saperstein R., Hirschmann R. Conformationally restricted bicyclic analogs of somatostatin. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2636–2640. doi: 10.1073/pnas.75.6.2636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Warren T. G., Shields D. Cell-free biosynthesis of somatostatin precursors: Evidence for multiple forms of preprosomatostatin. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3729–3733. doi: 10.1073/pnas.79.12.3729. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES